糖耐量异常与血管病变及糖基化终产物

被引：7

作者：

詹雅诗

冯烈

机构：

[1] 暨南大学附属第一医院内分泌科

来源：

中国病理生理杂志 | 2009年 / 25卷 / 02期

关键词：

糖耐量异常; 血管病变; 糖基化终产物,高级; 糖尿病;

D O I：

暂无

中图分类号：

R587.2 [糖尿病性昏迷及其他并发症];

学科分类号：

摘要：

The definition of impaired glucose tolerance (IGT) was first introduced by the National Diabetes Data Group at 1979. Recently the morbidity rate of IGT is soaring. About 10%-15% of patients with IGT will progress to type 2 diabetes mellitus (T2DM) which is approximately more than 100 times comparing with normal glucose tolerance people. Angiopathy can be detected in 40% patients with newly diagnosed IGT. Advanced glycation end products (AGEs) are closely related to angiopathy. Meanwhile there is some connection between IGT and AGEs. In this review, the relationship between IGT, agiopathy and AGEs is discussed.

引用

页码：405 / 408

页数：4

共 13 条

[11]

Peroxisome proliferator-activated receptor gamma down-regulates receptor for advanced glycation end products and inhibits smooth muscle cell proliferation in a diabetic and nondiabetic rat carotid artery injury model. Wang K,Zhou Z,Zhang M,et al. Journal of Pharmacology and Experimental Therapeutics . 2006

[12]

Early peripheral nerve abnormalities in impaired glucose tolerance. Cappellari,A,Airaghi,L,Capra,R,Ciammola,A,Branchi,A,Levi Minzi,G,Bresolin,N. Electromyography and Clinical Neurophysiology . 2005

[13]

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Yusuf S,Pfeffer MA,Swedberg K, et al. The Lancet . 2003

← 1 2 →